Globeflex Capital’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,336
Closed -$399K 457
2025
Q3
$399K Hold
6,336
0.06% 264
2025
Q2
$361K Hold
6,336
0.03% 285
2025
Q1
$355K Hold
6,336
0.03% 284
2024
Q4
$389K Hold
6,336
0.03% 289
2024
Q3
$424K Hold
6,336
0.04% 275
2024
Q2
$423K Hold
6,336
0.04% 265
2024
Q1
$451K Hold
6,336
0.04% 266
2023
Q4
$534K Sell
6,336
-3,002
-32% -$249K 0.05% 254
2023
Q3
$803K Hold
9,338
0.09% 200
2023
Q2
$870K Sell
9,338
-372
-4% -$35.1K 0.1% 192
2023
Q1
$920K Hold
9,710
0.11% 196
2022
Q4
$976K Hold
9,710
0.12% 186
2022
Q3
$828K Hold
9,710
0.14% 192
2022
Q2
$834K Hold
9,710
0.2% 148
2022
Q1
$873K Hold
9,710
0.18% 162
2021
Q4
$971K Buy
9,710
+3,374
+53% +$344K 0.2% 165
2021
Q3
$588K Hold
6,336
0.13% 219
2021
Q2
$539K Hold
6,336
0.1% 277
2021
Q1
$549K Hold
6,336
0.1% 284
2020
Q4
$534K Hold
6,336
0.11% 285
2020
Q3
$506K Buy
6,336
+731
+13% +$60.7K 0.13% 252
2020
Q2
$497K Buy
+5,605
New +$503K 0.13% 271

Other funds holding UTMD

Globeflex Capital's UTMD Position: Q4 2025 in Review

Globeflex Capital sold out of Utah Medical Products (UTMD) in Q4 2025, closing a stake of 6,336 shares — an estimated $399K sold.

Globeflex Capital first reported a position in UTMD in Q2 2020 and held it in 22 quarters. The position peaked at $976K in Q4 2022. 117 funds tracked by Wall St. Rank hold UTMD as of Q4 2025.

  • Globeflex Capital reported no remaining Utah Medical Products position as of Q4 2025 after selling out during the quarter.
  • Globeflex Capital sold 6,336 Utah Medical Products shares in Q4 2025, an estimated $399K.
  • Globeflex Capital first reported a position in Utah Medical Products in Q2 2020 and held it in 22 quarters.
  • Globeflex Capital's Utah Medical Products position peaked at $976K in Q4 2022.
  • 117 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2025.

Based on Globeflex Capital's 13F filing for Q4 2025, filed 11 Feb 2026.